NutriSystem Inc (NTRI) Jumps 10% on February 22

Equities Staff  |

NutriSystem Inc (NTRI) was among the biggest gainers on the Russell 2000 for Monday February 22 as the stock popped 10% to $22.23, representing a gain of $2.021 per share. Some 604,923 shares traded hands on 4,981 trades, compared with an average daily volume of 392,093 shares out of a total float of 29.18 million. The stock opened at $20.57 and traded with an intraday range of $22.98 to $20.45.

After today's gains, NutriSystem Inc reached a market cap of $648.66 million. NutriSystem Inc has had a trading range between $32.05 and $16.86 over the last year, and it had a 50-day SMA of $20.11 and a 200-day SMA of $23.99.

The stock has a P/E Ratio of 21.5.

NutriSystem Inc provides weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss.

NutriSystem Inc is based out of Fort Washington, PA and has some 417 employees. Its CEO is Dawn M. Zier.

For a complete fundamental analysis analysis of NutriSystem Inc, check out’s Stock Valuation Analysis report for NTRI. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Q BioMed CEO provides a Corporate Update

Denis Corin, CEO of Q BioMed Inc. ”Q“, a biomedical acceleration and development company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides a corporate update.

Emerging Growth

Permanent Techs Inc

Permanent Technologies Inc engages in the design and manufacture of multi-faceted, vibration-proof, self-locking nut and bolt systems for use in the fastener industry in the United States. The Company also…